高级检索
当前位置: 首页 > 详情页

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

机构: [1]Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [2]Department of Genetics and Genomic Sciences, Mount Sinai Medical Center, New York, NY, USA. [3]Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [4]The Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem , Jerusalem, Israel. [5]Department of Otolaryngology-Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China. [6]Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [7]Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY, USA. [8]Department of Otolaryngology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
出处:
ISSN:

摘要:
Nerves are integral to the adenoid cystic carcinoma (ACC) microenvironment. The strong association of ACC with perineural invasion (PNI) is considered a hallmark of this disease. In human salivary ACC, we identify intratumoral, small-caliber, disorganized sympathetic nerves not observed in other salivary neoplasms. Norepinephrine or sympathetic ganglia explants enhance ACC proliferation in vitro. Two novel orthotopic ACC patient-derived xenograft (PDX) models recapitulate ACC morphology and demonstrate sympathetic innervation. Pharmacologic or surgical blockade of sympathetic nerves decreases ACC PDX growth. Bulk RNA sequencing of salivary ACC reveals correlations between noradrenergic nerve development signatures and worse patient survival. Metastatic ACC foci exhibit lower nerve signature gene expression levels than primary ACC. Sympathetic innervation in ACC is distinct from PNI and reflects tumor axonogenesis driven by noradrenergic neural development programs. These programs support ACC progression, are associated with poor prognosis, and may be inhibited as a therapeutic strategy.© 2025 Chen et al.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 医学
小类 | 1 区 免疫学 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 免疫学 1 区 医学:研究与实验
JCR分区:
出版当年[2023]版:
Q1 IMMUNOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 IMMUNOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25463 今日访问量:0 总访问量:1498 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)